iCo Therapeutics Inc (OTCMKTS:ICOTF) was down 19.6% on Wednesday . The company traded as low as $0.04 and last traded at $0.04. Approximately 15,000 shares were traded during trading, an increase of 922% from the average daily volume of 1,468 shares. The stock had previously closed at $0.05.

About iCo Therapeutics (OTCMKTS:ICOTF)

iCo Therapeutics Inc, a biotechnology company, focuses on the identification, development, and commercialization of drug candidates to treat sight and life threatening diseases. Its in-licensed product candidates include iCo-008, a human monoclonal antibody, which is in Phase II clinical trial to treat sight threatening ocular allergies and various systemic disease indications; and Oral AmpB Delivery System that is in pre-clinical stage used for the treatment of systemic fungal infections.

Featured Story: What are no-load funds?

Receive News & Ratings for iCo Therapeutics Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for iCo Therapeutics and related companies with MarketBeat.com’s FREE daily email newsletter.



READ SOURCE

READ  Facebook suddenly banned ads for start-up that gives users an alternative to a Facebook product

WHAT YOUR THOUGHTS

Please enter your comment!
Please enter your name here